ArticleThe journal of prevention of Alzheimer's disease2019

Designing Trials of Disease Modifying Agents for Early and Preclinical Alzheimer's Disease Intervention: What Evidence is Meaningful to Patients, Providers, and Payers?

D A Messner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.